Carlos Clavel received his BS and MS in Biological Sciences from Saint Louis University in the US. He finished his PhD training in Cell Therapy at the University of Navarra, Spain and then joined the laboratory of Catherine Verfaillie working with Multipotent Adult Progenitor Cells in her laboratories in Minnesota, US and Leuven, Belgium. His research then shifted to understanding how stem cells are instructed to display their potential, and he subsequently joined Michael Rendl’s laboratory at Mount Sinai School of Medicine in New York where his research focused on the transcriptional control of the hair-inducing fate of dermal papilla niche cells. Clavel is now a Principal Investigator at A*STAR Skin Research Labs (A*SRL) where his group is focusing on understanding the regulation of the hair follicle stem cell niche and its implication in novel therapies for skin disorders.
